Germany
Japan
United Kingdom
China
Innate Immunity
View as table Download
MAPK1 (Myc-DDK-tagged)-Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
USD 1,007.00
2 Weeks
Lenti ORF particles, MAPK1 (mGFP-tagged) - Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
USD 1,007.00
2 Weeks
Lenti ORF particles, MAPK1 (Myc-DDK tagged) - Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
USD 1,007.00
7 Weeks
Lenti ORF particles, MAPK1 (mGFP-tagged) - Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
USD 1,007.00
5 Weeks
Lenti ORF particles, MAPK1 (Myc-DDK tagged) - Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
Recombinant protein of human mitogen-activated protein kinase 1 (MAPK1), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
USD 509.00
2 Weeks
USD 509.00
2 Weeks
Active filters
Target Symbol
- ERK2
Filter by
Species
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Expression Hosts
Lentivirus
Vectors
Modifications
Assay Types
Assay Platforms
QC Levels
Mammalian Cell Selection
Pathways
- Acute myeloid leukemia (100)
- Adherens junction (100)
- Alzheimer's disease (100)
- Axon guidance (100)
- B cell receptor signaling pathway (100)
- Bladder cancer (100)
- Chemokine signaling pathway (100)
- Chronic myeloid leukemia (100)
- Colorectal cancer (100)
- Dorso-ventral axis formation (100)
- Endometrial cancer (100)
- ErbB signaling pathway (100)
- Fc epsilon RI signaling pathway (100)
- Fc gamma R-mediated phagocytosis (100)
- Focal adhesion (100)
- Gap junction (100)
- Glioma (100)
- GnRH signaling pathway (100)
- Insulin signaling pathway (100)
- Long-term depression (100)
- Long-term potentiation (100)
- MAPK signaling pathway (100)
- Melanogenesis (100)
- Melanoma (100)
- NOD-like receptor signaling pathway (100)
- Natural killer cell mediated cytotoxicity (100)
- Neurotrophin signaling pathway (100)
- Non-small cell lung cancer (100)
- Oocyte meiosis (100)
- Pancreatic cancer (100)
- Pathways in cancer (100)
- Prion diseases (100)
- Progesterone-mediated oocyte maturation (100)
- Prostate cancer (100)
- Regulation of actin cytoskeleton (100)
- Renal cell carcinoma (100)
- T cell receptor signaling pathway (100)
- TGF-beta signaling pathway (100)
- Thyroid cancer (100)
- Toll-like receptor signaling pathway (100)
- Type II diabetes mellitus (100)
- VEGF signaling pathway (100)
- Vascular smooth muscle contraction (100)
- mTOR signaling pathway (100)